कंपनी का अवलोकन
Sharps Technology, Inc. operates as a specialized entity within the healthcare sector, specifically focusing on the medical instruments and supplies industry. The company's core business involves manufacturing and distributing smart-safety syringe products designed to enhance waste management capabilities through advanced syringe technologies. As of the latest data, the organization maintains a market capitalization of $63.02M and reports an annual revenue of $204,120 over the trailing twelve months. Although the exact number of employees is not publicly disclosed in the available records, the company's financial structure suggests a small-cap profile with significant concentration in its specific niche. The low market cap relative to the high price-to-sales ratio indicates that the market is pricing the company based on future potential rather than current operational scale, while the minimal revenue figure highlights the early-stage or highly specialized nature of its product distribution model within the broader healthcare landscape.
वित्तीय स्वास्थ्य
The company reports a trailing twelve-month revenue of $204,120, yet this figure contrasts sharply with a net income of -$270,335,424, revealing a severely distorted cost structure where expenses far exceed generated sales. The EBITDA stands at -$13,159,940, indicating that core operational profitability is currently negative before financing and tax adjustments. Despite these negative income metrics, the company possesses a substantial cash reserve of $10.38M, which generates a free cash flow of $93.85M, providing significant financial flexibility to fund operations or strategic initiatives without immediate external financing. The gross margin is recorded at -202.5%, the operating margin at -6512.1%, and the profit margin at 0.0%, collectively pointing to an accounting anomaly or extreme operational inefficiency where costs are not properly matched against revenue in the standard financial reporting. On the liability side, total cash of $10.38M exceeds total debt of $3.08M, resulting in a debt-to-equity ratio of 1.17, which suggests a leveraged position that is partially mitigated by the high cash liquidity. The current ratio is reported at 4.02, indicating that the company holds more than four times the assets required to cover its short-term liabilities, reflecting strong short-term liquidity despite the earnings deficit. Furthermore, the return on equity is -203.0% and the return on assets is -6.0%, metrics that demonstrate that management has not yet generated positive returns on the capital invested, likely due to the current stage of development or losses in the initial product rollout.
मूल्यांकन आकलन
The valuation metrics present a complex picture with a P/E Ratio (TTM) listed as N/A due to negative earnings, while the forward P/E is calculated at -10.87, implying that expected future earnings are also anticipated to be negative or that the market is pricing in significant turnaround time. The price-to-book ratio is 0.10, suggesting that the company is trading at a fraction of its book value, which typically indicates deep value but in this context reflects the substantial losses impacting the equity value. Alternative valuation multiples such as the price-to-sales ratio of 308.76 and an EV/EBITDA of -4.23 indicate that investors are assigning a high multiple to sales, likely betting on the digital asset treasury strategy or future product adoption rather than current profitability. The stock has exhibited significant volatility with a 52-week high of $18.23 and a 52-week low of $1.42, placing the current trading environment within a wide range that reflects high investor sentiment swings. With a beta of 2.07, the stock demonstrates high price volatility relative to the broader market, meaning it is expected to move more than twice as much as the overall market index in either direction. These valuation figures collectively suggest that the market is pricing the company based on speculative growth potential rather than established financial fundamentals.
Growth & Income
The revenue growth year-over-year and earnings growth year-over-year are both listed as N/A, meaning historical growth trajectories cannot be calculated from the current data points, but the earnings figure of -$270,335,424 implies that earnings are currently contracting or have never been profitable relative to the revenue base. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, indicating that the firm retains all available cash to fund operations or strategic investments rather than distributing income to shareholders. Consequently, the capital allocation strategy focuses entirely on internal reinvestment to achieve future profitability rather than providing regular income to investors. The overall growth and income profile is characterized by high volatility and a lack of current profitability, relying on the cash balance and treasury strategy to navigate the path toward positive earnings.